70以上 pancreatic cancer exocrine vs endocrine 875819-Pancreatic cancer exocrine endocrine
Patients with pathologically confirmed stage IV exocrine pancreatic cancer who have received at least two lines of systemic therapy for metastatic disease Up to 10 of prior lines of systemic therapy (including prior cisplatin), chemoradiotherapy, radiotherapy or investigational agents the patient has received are allowed in order to be eligible, as long as all eligibility criteriaEndocrine function is nearly always maintained;However, patients with extensive cystic disease may require pancreatic surgery and pancreatic exocrine supplementation Pancreatic NETs are usually nonfunctional, but they can metastasize (to the lymph nodes and the liver) The risk of pancreatic NET metastasis was analyzed in a large cohort of Sex Differences In The Exocrine Pancreas And Associated Diseases Cellular And Molecular Gastroenterology And Hepatology Pancreatic cancer exocrine endocrine